HomeCBHD • ETR
add
Coloplast A/S
Previous close
€105.10
Year range
€104.00 - €130.95
Market cap
175.69B DKK
Avg Volume
163.00
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Market news
Financials
Income Statement
Revenue
Net income
(DKK) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 7.03B | 6.36% |
Operating expense | 2.84B | 5.82% |
Net income | 1.04B | -13.86% |
Net profit margin | 14.86 | -19.02% |
Earnings per share | 6.38 | 17.06% |
EBITDA | 2.24B | 5.16% |
Effective tax rate | 40.98% | — |
Balance Sheet
Total assets
Total liabilities
(DKK) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 906.00M | -1.09% |
Total assets | 48.34B | -0.52% |
Total liabilities | 32.88B | -1.76% |
Total equity | 15.46B | — |
Shares outstanding | 225.17M | — |
Price to book | 1.53 | — |
Return on assets | 9.92% | — |
Return on capital | 11.84% | — |
Cash Flow
Net change in cash
(DKK) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 1.04B | -13.86% |
Cash from operations | 2.01B | 12.25% |
Cash from investing | -133.00M | 50.19% |
Cash from financing | -1.76B | -19.23% |
Net change in cash | 118.00M | 2,260.00% |
Free cash flow | 1.74B | 18.46% |
About
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
Founded
1957
Headquarters
Website
Employees
16,628